Financials
- Market Capitalization 12.59 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
0.13
Relación precio/flujo de caja
14.27
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4705 | KALA KALA BIO, Inc. - Common Stock | 0.67 USD | -2.90% | -20.24% | -14.10% | -94.42% | 12.96 M USD | ||
| 4713 | PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.09 USD | -3.54% | -4.39% | +5.83% | -8.40% | 12.66 M USD | ||
| 4718 | QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 6.22 USD | +1.63% | +16.92% | +46.01% | -33.26% | 12.49 M USD | ||
| 4720 | MBRX Moleculin Biotech, Inc. - Common Stock | 0.64 USD | -1.54% | +6.67% | +72.97% | -79.68% | 12.47 M USD |